AUTHORS: Magliocca, Aurora, MD et al Anesthesia & Analgesia: January 2018 – Volume 126 – Issue 1 – p 85–92 BACKGROUND: Orthotopic liver transplantation (OLT) is characterized by significant intraoperative hemodynamic variability. Accurate and real-time cardiac output (CO) monitoring aids clinical decision making during OLT. The purpose of this study is to compare accuracy, precision, and trending […]
Read MoreAUTHORS: Sabourdin, Nada, MD et al Anesthesia & Analgesia: January 2018 – Volume 126 – Issue 1 – p 70–77 BACKGROUND: Pupillometry allows the measurement of pupillary diameter variations in response to nociceptive stimuli. This technique has been used to monitor the balance between analgesia and nociception. Under general anesthesia, the amplitude of pupillary dilation is related […]
Read MoreAuthor: Martin J. London, M.D., F.A.S.E. Anesthesiology 6 2018, Vol.128, 1055-1059. “…what constitutes [perioperative] myocardial infarction, its subtypes, and treatment strategies[?]” In this issue of the Anesthesiology, Helwani et al.1 address the etiology, classification, and prognosis of perioperative myocardial infarction (MI), a subject of investigation for more than 75 yr now. A unique feature of their study is […]
Read MoreAuthors: Daniel I. McIsaac, M.D., M.P.H., F.R.C.P.C. et al Anesthesiology 6 2018, Vol.128, 1140-1150. Background: Polypharmacy is increasingly prevalent in older patients and is associated with adverse events among medical patients. The impact of polypharmacy on outcomes after elective surgery is poorly described. The authors’ objective was to measure the association of polypharmacy with survival, complications, and […]
Read MoreThe FDA has approved Lucemyra (lofexidine hydrochloride), a non-opioid, to help lessen the symptoms of opioid withdrawal in adults. Oral lofexidine, a selective alpha 2-adrenergic receptor agonist that inhibits the release of norepinephrine, is approved for up to 14 days of treatment. The FDA notes that it doesn’t treat opioid use disorder, but it can […]
Read More